Clinical Trials Directory

Trials / Completed

CompletedNCT03848442

'Uptime' Participation Intervention in Girls and Women With Rett Syndrome

Feasibility and Effectiveness of an Individualized 12-week 'Uptime' Participation Intervention (U-PART) in Girls and Women With Rett Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Female
Age
5 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate the feasibility and health-related effects of an individualized 12wk 'uptime' participation intervention in girls and women with Rett syndrome. Girls and women above 5 years of age with Rett syndrome and a confirmed MECP2 mutation will be included. Each individual program focuses on participation in enjoyable activities to promote 'uptime' in home, school/day center and community settings. Primary outcomes are sedentary time and daily steps. Secondary outcomes are gross motor skills, walking capacity, quality of life and participation-level goals. Outcomes are evaluated on four occasions: at baseline and after a 6-week interval, immediately following the 12-week intervention program and 12 weeks after the intervention program.

Conditions

Interventions

TypeNameDescription
OTHER'Uptime' participationThe intervention are designed for each individual and are consistent with the model for participation-based interventions. The interventions are goal-oriented (meaningful and family/client-selected goals), family/client-centered (promoted self-determination and decision making), collaborative (partnership between caregivers), strength-based (built on participant and caregiver strengths) and ecological (natural environment and real-life experiences). Design of the intervention comprised three steps: 1) Preparation period (6 weeks); 2) Intervention period (12 weeks); 3) Follow-up period (12 weeks)

Timeline

Start date
2017-02-07
Primary completion
2017-12-15
Completion
2017-12-15
First posted
2019-02-20
Last updated
2019-02-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03848442. Inclusion in this directory is not an endorsement.